🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

3 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 3mg UL 10mg

Other Ingredients

Dicalcium Phosphate Cellulose Croscarmellose Sodium Stearic Acid Magnesium Stearate Silica May also contain

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested Use: For adults, take one (1) tablet only at bedtime, as Melatonin may produce drowsiness. Not intended for use by persons under the age of 18. Limit use to two months with a break of one week.

⚠️ Warnings & Precautions

Not intended for use by persons under the age of 18.

Tamper Evident: Do not use if imprinted seal under cap is missing or broken.

Warnings: Not intended for use by pregnant or nursing women.

Ask a doctor before use if you have an autoimmune condition, a depressive disorder, or are under a doctor's care for any other condition.

Ask a doctor or pharmacist before use if you are taking any tranquilizers, sedatives or any other medication.

Stop use and contact your doctor if any adverse reactions occur.

You may experience some residual drowsiness. Do not drive, operate machinery or consume alcohol when taking this product.

Keep out of reach of children

Additional Information

Value size The sensible choice for price and health

Store at room temperature

Product Details

UPC / SKU 3 57896 86420 0
DSLD Entry Date 2019-09-24
Product Type Non-Nutrient/Non-Botanical
Form Tablet or Pill
Brand Health Star
DSLD ID 206591
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →